Respiratory Muscle Training in Scleroderma
Effects of Respiratory Muscle Training in Patients With Scleroderma With Pulmonary Involvement
1 other identifier
interventional
30
0 countries
N/A
Brief Summary
The aim of this study is to investigate the effects of IMT on respiratory muscle strength, pulmonary function tests, quality of life aerobic capacity, dyspnea, fatigue and physical activity level in scleroderma patients with ILD. The study will include 30 Scleroderma + ILD patients who are under follow-up in Fırat University Rheumatology Department. Patients will be randomly divided into two groups. High intensity intermittent inspiratory muscle training (H-IMT) will be applied to the respiratory muscle training group in addition to the exercise program. Respiratory muscle strength will be assessed by maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP); aerobic capacity will be assessed by exercise test and VO2max. Dyspnea will be assessed with the Modified Medical Research Council Scale; fatigue with the Fatigue Severity Scale; quality of life with the Scleroderma Health Assessment Questionnaire; physical activity level with the International Physical Activity Scale - Short Form
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2024
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 8, 2024
CompletedStudy Start
First participant enrolled
November 10, 2024
CompletedFirst Posted
Study publicly available on registry
November 12, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 20, 2025
CompletedNovember 12, 2024
November 1, 2024
2 months
November 8, 2024
November 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Respiratory muscle strength
Respiratory muscle strength will be assessed with an intraoral pressure gauge. Maximal Inspiratory Pressure (MIP) and Maximal Expiratory Pressure (MEP) are commonly used non-invasive methods to determine respiratory muscle strength. These are intraoral pressures measured at maximum respiration against a valve that closes the airways. When applying MIP, the patient is asked to perform maximal expiration.
up to 8 weeks
Secondary Outcomes (1)
Fatigue
up to 8 weeks
Study Arms (2)
IMT group
EXPERIMENTALHigh intensity intermittent inspiratory muscle training (H-IMT) will be applied. This training will be performed with Power breath (POWERbreathe Classic Light Resistance, PowerBreath, IMT Technologies Ltd, Birmingham, UK) respiratory muscle training device. The H-IMT will be performed in seven sets of three-minute cycles consisting of two minutes of training followed by one minute of rest in the training workload. Each session will consist of 14 minutes of loading and seven minutes of rest for a total of 21 minutes.
Exercise group
OTHERStretching exercises for pectoral muscles, neck muscles and back muscles, strengthening exercises for upper extremity and back muscles and posture exercises will be applied.
Interventions
The H-IMT will be performed in seven sets of three-minute cycles consisting of two minutes of training followed by one minute of rest in the training workload. Each session will consist of 14 minutes of loading and seven minutes of rest for a total of 21 minutes.
Stretching exercises for pectoral muscles, neck muscles and back muscles, strengthening exercises for upper extremity and back muscles and posture exercises will be applied.
Eligibility Criteria
You may qualify if:
- years old
- Patients whose medical treatment has not changed in the last three months
- Patients who volunteered to participate in the study and were cooperative
- Literate patients
- Patients followed with a diagnosis of SSc
You may not qualify if:
- Patients who are pregnant
- Patients with a diagnosis of malignancy
- Patients with other concomitant systemic inflammatory rheumatic diseases
- Patients with neurological, orthopedic or congenital problems that prevent physical activity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Firat Universitylead
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Firat University
Study Record Dates
First Submitted
November 8, 2024
First Posted
November 12, 2024
Study Start
November 10, 2024
Primary Completion
January 10, 2025
Study Completion
February 20, 2025
Last Updated
November 12, 2024
Record last verified: 2024-11